Ractopamine is a synthetic beta-adrenoceptor agonist (commonly known as beta-stimulant) compound. It is a low-toxic, fast-metabolizing clenbuterol developed by an American pharmaceutical company. Substitute, second generation clenbuterol.

Because of its ability to regulate protein synthesis, it is also called a protein repartitioner abroad. It is mainly used clinically to treat bronchial asthma, congestive heart failure, and muscular dystrophy.

Extended information

The toxicity of ractopamine is much lower than other clenbuterol additives with the same function. Regular doses of clenbuterol drugs can be metabolized and excreted from the body without causing harm to the body.

However, excessive intake of ractopamine will cause varying degrees of poisoning reactions in the human body, and its symptoms Symptoms similar to those of animal poisoning include muscle tremors, limb paralysis, tachycardia, arrhythmia, abdominal pain, muscle pain, nausea and dizziness. In severe cases, it can cause high blood pressure, heart disease and even death.

When the dosage of ractopamine is 5 to 10 times the clinical dosage, it can increase the carcass protein content, reduce fat tissue, and effectively improve lean meat rate and feed utilization.

Huaibin, China-Scientific interpretation of "ractopamine"